Literature DB >> 31430754

Expression Analyses of POGZ, A Responsible Gene for Neurodevelopmental Disorders, during Mouse Brain Development.

Kyoko Ibaraki1, Nanako Hamada1, Ikuko Iwamoto1, Hidenori Ito1, Noriko Kawamura1, Rika Morishita1, Hidenori Tabata1, Koh-Ichi Nagata2,3.   

Abstract

POGZ is a heterochromatin protein 1 α-binding protein and regulates gene expression. On the other hand, accumulating pieces of evidence indicate that the POGZ gene abnormalities are involved in various neurodevelopmental disorders. In this study, we prepared a specific antibody against POGZ, anti-POGZ, and carried out biochemical and morphological characterization with mouse brain tissues. Western blotting analyses revealed that POGZ is expressed strongly at embryonic day 13 and then gradually decreased throughout the brain development process. In immunohistochemical analyses, POGZ was found to be enriched in cerebrocortical and hippocampal neurons in the early developmental stage. The nuclear expression was also detected in Purkinje cells in cerebellum at postnatal day (P)7 and P15 but disappeared at P30. In primary cultured hippocampal neurons, while POGZ was distributed mainly in the nucleus, it was also visualized in axon and dendrites with partial localization at synapses in consistency with the results obtained in biochemical fractionation analyses. The obtained results suggest that POGZ takes part in the regulation of synaptic function as well as gene expression during brain development.
© 2019 S. Karger AG, Basel.

Entities:  

Keywords:  Antibody; Cerebellum; Cerebral cortex; Hippocampus; Neuron; POGZ

Mesh:

Substances:

Year:  2019        PMID: 31430754     DOI: 10.1159/000502128

Source DB:  PubMed          Journal:  Dev Neurosci        ISSN: 0378-5866            Impact factor:   2.984


  6 in total

1.  Loss of POGZ alters neural differentiation of human embryonic stem cells.

Authors:  Lu Deng; Sandra P Mojica-Perez; Ruth D Azaria; Mark Schultz; Jack M Parent; Wei Niu
Journal:  Mol Cell Neurosci       Date:  2022-03-31       Impact factor: 4.626

2.  A novel, de novo intronic variant in POGZ causes White-Sutton syndrome.

Authors:  Ashanta Merriweather; David R Murdock; Jill A Rosenfeld; Hongzheng Dai; Shamika Ketkar; Lisa Emrick; Sarah Nicholas; Richard A Lewis; Carlos A Bacino; Daryl A Scott; Brendan Lee; Vernon Reid Sutton; Lorraine Potocki; Lindsay C Burrage
Journal:  Am J Med Genet A       Date:  2022-04-09       Impact factor: 2.578

3.  Epigenome-wide association study of level and change in cognitive abilities from midlife through late life.

Authors:  Ida K Karlsson; Malin Ericsson; Yunzhang Wang; Juulia Jylhävä; Sara Hägg; Anna K Dahl Aslan; Chandra A Reynolds; Nancy L Pedersen
Journal:  Clin Epigenetics       Date:  2021-04-21       Impact factor: 6.551

4.  Identification of abnormally high expression of POGZ as a new biomarker associated with a poor prognosis in osteosarcoma.

Authors:  Sikuan Zheng; Yue Liu; Haohe Sun; Jingyu Jia; Tianlong Wu; Rui Ding; Xigao Cheng
Journal:  Eur J Histochem       Date:  2021-09-03       Impact factor: 1.966

5.  Deficiency of CHAMP1, a gene related to intellectual disability, causes impaired neuronal development and a mild behavioural phenotype.

Authors:  Masayoshi Nagai; Kenji Iemura; Takako Kikkawa; Sharmin Naher; Satoko Hattori; Hideo Hagihara; Koh-Ichi Nagata; Hayato Anzawa; Risa Kugisaki; Hideki Wanibuchi; Takaya Abe; Kenichi Inoue; Kengo Kinoshita; Tsuyoshi Miyakawa; Noriko Osumi; Kozo Tanaka
Journal:  Brain Commun       Date:  2022-08-30

6.  Pogz deficiency leads to transcription dysregulation and impaired cerebellar activity underlying autism-like behavior in mice.

Authors:  Reut Suliman-Lavie; Ben Title; Yahel Cohen; Nanako Hamada; Maayan Tal; Nitzan Tal; Galya Monderer-Rothkoff; Bjorg Gudmundsdottir; Kristbjorn O Gudmundsson; Jonathan R Keller; Guo-Jen Huang; Koh-Ichi Nagata; Yosef Yarom; Sagiv Shifman
Journal:  Nat Commun       Date:  2020-11-17       Impact factor: 14.919

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.